Tianjin Lisheng Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of March 2026: 17.92%

Tianjin Lisheng Pharmaceutical Co Ltd (002393) has an Asset Resilience Ratio of 17.92% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥991.31 Million

≈ $145.06 Million USD Cash + Short-term Investments

Total Assets

CN¥5.53 Billion

≈ $809.66 Million USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2022–2025)

This chart shows how Tianjin Lisheng Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. Check Tianjin Lisheng Pharmaceutical Co Ltd (002393) strategic investment index to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Tianjin Lisheng Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 002393 market cap overview.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥991.31 Million	17.92%
Total Liquid Assets	CN¥991.31 Million	17.92%

Asset Resilience Insights

Good Liquidity Position: Tianjin Lisheng Pharmaceutical Co Ltd maintains a healthy 17.92% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

Tianjin Lisheng Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Tianjin Lisheng Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Alkem Laboratories Limited NSE:ALKEM	Drug Manufacturers - Specialty & Generic	31.91%
Beijing Tongrentang Co Ltd SHG:600085	Drug Manufacturers - Specialty & Generic	0.50%
Jiangsu Nhwa Pharmaceutical Co Ltd SHE:002262	Drug Manufacturers - Specialty & Generic	28.06%
Jilin Aodong Pharmaceutical Group Co Ltd SHE:000623	Drug Manufacturers - Specialty & Generic	4.97%
Fujian Cosunter Pharmaceutical Co Ltd SHE:300436	Drug Manufacturers - Specialty & Generic	-2.56%
Beijing New Oriental Star Petrochemical Engineering Co Ltd SHE:002755	Drug Manufacturers - Specialty & Generic	24.59%
Zhejiang Medicine Co Ltd SHG:600216	Drug Manufacturers - Specialty & Generic	1.85%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%

Annual Asset Resilience Ratio for Tianjin Lisheng Pharmaceutical Co Ltd (2022–2025)

The table below shows the annual Asset Resilience Ratio data for Tianjin Lisheng Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	18.27%	CN¥1.02 Billion ≈ $149.30 Million	CN¥5.58 Billion ≈ $817.17 Million	+8.36pp
2024-12-31	9.91%	CN¥573.36 Million ≈ $83.90 Million	CN¥5.79 Billion ≈ $846.60 Million	+5.91pp
2023-12-31	4.00%	CN¥231.26 Million ≈ $33.84 Million	CN¥5.78 Billion ≈ $845.88 Million	+0.21pp
2022-12-31	3.79%	CN¥200.32 Million ≈ $29.31 Million	CN¥5.29 Billion ≈ $774.25 Million	--

pp = percentage points

About Tianjin Lisheng Pharmaceutical Co Ltd

SHE:002393 China Drug Manufacturers - Specialty & Generic

Market Cap

$656.92 Million

CN¥4.49 Billion CNY

Market Cap Rank

#10801 Global

#2919 in China

Share Price

CN¥14.53

Change (1 day)

+0.97%

52-Week Range

CN¥13.78 - CN¥26.70

All Time High

CN¥46.19